Assistant Professor, Pediatric Hematology and Oncology, Baylor College of Medicine
Pediatric Hematology & Oncology
Dr. Terzah M. Horton, MD
|
|
Give Review
Terzah Horton works in the field of Pediatric Hematology & Oncology. She researched medicine at Emory University School of Medicine. Emory University School of Medicine has a rank of 23 in research and a 42 in primary care Doctor Terzah M. Horton, MD is also published. She has 29 publications published. The lastest publication: "Surgical treatment of epilepsy: Robert Wood Johnson experience.'
Publications
- A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary Acute myeloid leuke...
- AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent Acute myeloid ...
- Mentoring in Pediatric Oncology: A Report from the Children's Oncology Group Young Investigator Committee.
- A Pediatric Phase 1 Trial of Vorinostat and Temozolomide in Relapsed or Refractory Primary Brain or Spinal Cord Tumors: A Children's Oncology Group Phase 1 Consortium ...
- A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916).
- Pediatric Hodgkin Lymphoma: Are We Over-scanning Our Patients?
- Improving T-cell therapy for relapsed EBV-negative Hodgkin Lymphoma by targeting upregulated MAGE-A4.
- Development and validation of a fluorogenic assay to measure separase enzyme activity.
- Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in Leukemia cells: influence of mismatch repair status and O6-methylgu...
- A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory Leukemia: a Children's Oncology Group study.
- Diverse pathways mediate chemotherapy-induced cell death in Acute lymphoblastic leukemia cell lines.
- Phase I trial and pharmacokinetic study of raltitrexed in children with recurrent or refractory Leukemia: a pediatric oncology group study.
- Outcomes for children with gallbladder abnormalities and sickle cell Disease.
- Case series of thrombotic Thrombocytopenic purpura in children and adolescents.
- Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric Acute lymphocytic leukemia (ALL): review from an int...
- Educational paper. The development of new therapies for pediatric oncology.
- Bortezomib interactions with chemotherapy agents in Acute leukemia in vitro.
- A Phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory Leukemia in children: a Children''s Oncology Group study.
- Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent Leukemia: a Children''s Oncology Group Study.
- Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015).
- Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates.
- Targeting the Bcl-2 family of proteins in Hodgkin Lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737.
- Defining and managing career challenges for mid-career and senior stage pediatric hematologist/oncologists.
- Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis.
- Endogenous knockdown of survivin improves chemotherapeutic response in ALL models.
- Aseptic meningitis in a child after systemic treatment with high dose cytarabine.
- Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis.
- Surgical treatment of epilepsy: Robert Wood Johnson experience.
Conditions Treated
- Acute Leukemia
- Anemia
- Coagulation Disorders (incl. Hemophilia)
- Hodgkin's Disease
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
Baylor College of Medicine -
Emory University School of Medicine
Hospital
-
Texas Children's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Nidale G. Tarek, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary N. Suell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nabil M. Ahmed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robin Parihar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Piti Techavichit, MD |